Hazlett, Burt & Watson, Inc. Viatris Inc Transaction History
Hazlett, Burt & Watson, Inc.
- $226 Million
- Q4 2024
A detailed history of Hazlett, Burt & Watson, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Hazlett, Burt & Watson, Inc. holds 5,985 shares of VTRS stock, worth $64,638. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,985
Previous 5,985
-0.0%
Holding current value
$64,638
Previous $69,000
7.25%
% of portfolio
0.03%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding VTRS
# of Institutions
1,136Shares Held
987MCall Options Held
2.43MPut Options Held
2M-
Vanguard Group Inc Valley Forge, PA142MShares$1.54 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$688 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$676 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$634 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.1B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...